Bicycle Therapeutics (BCYC) EBT Margin (2018 - 2026)
Bicycle Therapeutics posted quarterly EBT Margin of 6837.99% for Q1 2026, down 621816.0% year-on-year from N/an in Q1 2025, and down 12740.82% on a QoQ basis from 53.25% in Q4 2025.
Bicycle Therapeutics (BCYC) has 9 years of EBT Margin data on file, last reported at 6837.99% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 621816.0% year-over-year to 6837.99%; the trailing twelve-month figure through Mar 2026 stood at 353.2% (down 24001.0% YoY), and the FY2025 full-year result was 310.61%, down 32709.0% from the prior year.
- EBT Margin for Q1 2026 stood at 6837.99%, down from 53.25% in the prior quarter.
- Across five years, EBT Margin topped out at 3416.24% in Q4 2024 and bottomed at 6837.99% in Q1 2026.
- The 5-year median for EBT Margin is 619.84% (2025), against an average of 909.36%.
- The widest annual swing landed in 2024, when EBT Margin surged 440202 bps; it then slumped 621816 bps in 2026.
- A 5-year view of EBT Margin shows it stood at 386.1% in 2022, then tumbled by 155 bps to 985.78% in 2023, then surged by 447 bps to 3416.24% in 2024, then slumped by 102 bps to 53.25% in 2025, then tumbled by 12741 bps to 6837.99% in 2026.
- The last three EBT Margin figures came in at 6837.99% (Q1 2026), 53.25% (Q4 2025), and 501.92% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 18.99% |
| 10 | Bicycle Therapeutics | 326.82 Mn | 326.82 Mn | - | -6,837.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6,837.99% |
| Dec 31, 2025 | -53.25% |
| Sep 30, 2025 | -501.92% |
| Jun 30, 2025 | -2,711.75% |
| Mar 31, 2025 | -619.84% |
| Dec 31, 2024 | 3,416.24% |
| Sep 30, 2024 | -2,027.28% |
| Jun 30, 2024 | -424.07% |
| Mar 31, 2024 | -258.78% |
| Dec 31, 2023 | -985.78% |
| Sep 30, 2023 | -889.87% |
| Jun 30, 2023 | -378.35% |
| Mar 31, 2023 | -810.50% |
| Dec 31, 2022 | -386.10% |
| Sep 30, 2022 | -940.30% |
| Jun 30, 2022 | -324.70% |
| Mar 31, 2022 | -724.95% |
| Dec 31, 2021 | -1,174.06% |
| Sep 30, 2021 | -348.33% |
| Jun 30, 2021 | -1,012.49% |
| Mar 31, 2021 | -914.33% |
| Dec 31, 2020 | -454.47% |
| Sep 30, 2020 | -275.98% |
| Jun 30, 2020 | -777.34% |
| Mar 31, 2020 | -1,012.49% |
| Dec 31, 2019 | -86.04% |
| Sep 30, 2019 | -1,598.21% |
| Jun 30, 2019 | -662.42% |
| Mar 31, 2019 | -100.61% |
| Dec 31, 2018 | -628.29% |
| Sep 30, 2018 | -477.76% |
| Jun 30, 2018 | -299.76% |
| Mar 31, 2018 | -104.34% |